Explanatory factors
RLS
There was substantial between-participants variation in well-tolerated percentage opioid reduction during TOMAC treatment, which ranged from 0 to 75%. The most significant predictive factor of this outcome was patient-reported acute relief of RLS symptoms Relationship between acute TOMAC response and opioid dose reduction 